“We want to follow the science here. We don’t to get ahead of it,” Gilead Sciences CEO Daniel O’Day told CNBC on Monday. Source


And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.